We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Draft Guidance Suggests Updated Assessment of Suicidal Events in Trials
Draft Guidance Suggests Updated Assessment of Suicidal Events in Trials
August 17, 2012
Drugmakers should use an updated instrument for the prospective assessment of suicidal thoughts and behaviors during clinical trials and follow new FDA advice on which trials and patients need such assessments, according to a new draft guidance.